文献速递产科母胎医学

产科试验中结局偏好排序的适用性:以ARRIVE试验为例的说明与应用

Desirability of outcome ranking for obstetrical trials: illustration and application to the ARRIVE trial.
PubMed 文献 · Am J Obstet Gynecol · 2023-09-22

本研究将结局偏好排序(DOOR)方法应用于ARRIVE试验的6096名参与者数据,将母婴配对结局按偏好分为8类。结果显示,随机接受39周择期引产的患者获得更优配对结局的概率为53%(95%CI 51-54),避免剖宫产的DOOR概率为52%(95%CI 51-53),且未以器械阴道分娩或围产儿不良结局为代价。作者认为DOOR是有用的产科试验工具。

要点

  • DOOR方法可同时考虑母婴多个结局,适用于产科试验。
  • 39周择期引产获得更优配对结局的概率为53%(95%CI 51-54)。
  • 择期引产避免剖宫产的DOOR概率为52%(95%CI 51-53),未牺牲围产儿结局。

核心结论

  • DOOR方法是有用的产科试验工具,能同时呈现干预对多个母婴配对结局的影响,可能有助于更好地将数据转化为决策和以人为中心的照护。

研究设计与样本

  • 本研究的二次分析将DOOR方法应用于Eunice Kennedy Shriver国家儿童健康与人类发展研究所母胎医学单位网络ARRIVE试验的数据。
  • 分析纳入ARRIVE试验全部6096名参与者。
  • 将母婴配对结局按总体偏好分为8类,从最偏好的无严重新生儿并发症的阴道自然分娩到最不偏好的剖宫产伴围产儿死亡。
  • 通过估计39周择期引产相比期待管理获得更优配对结局的概率来比较DOOR分布。
  • 采用部分学分策略在100分制上对结局评分,并用t检验估计两组总体治疗评分的差异。

主要发现

  • 随机接受择期引产的患者获得更优配对结局的概率为53%(95%CI 51-54),提示择期引产在同时考虑多个结局时使母婴配对总体结局更优。
  • 择期引产避免剖宫产的DOOR概率为52%(95%CI 51-53),且未以器械阴道分娩或围产儿更差结局(即存活伴严重新生儿并发症或围产儿死亡)为代价。
  • 在大多数部分学分评分场景中,随机接受择期引产也具有优势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In randomized trials, 1 primary outcome is typically chosen to evaluate the consequences of an intervention, whereas other important outcomes are relegated to secondary outcomes. This issue is amplified for many obstetrical trials in which an intervention may have consequences for both the pregnant person and the child. In contrast, desirability of outcome ranking, a paradigm shift for the design and analysis of clinical trials based on patient-centric evaluation, allows multiple outcomes-including from >1 individual-to be considered concurrently. OBJECTIVE: This study aimed to describe desirability of outcome ranking methodology tailored to obstetrical trials and to apply the methodology to maternal-perinatal paired (dyadic) outcomes in which both individuals may be affected by an intervention but may experience discordant outcomes (eg, an obstetrical intervention may improve perinatal but worsen maternal outcomes). STUDY DESIGN: This secondary analysis applies the desirability of outcome ranking methodology to data from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network ARRIVE trial. The original analysis found no substantial difference in the primary (perinatal composite) outcome, but a decreased risk of the secondary outcome of cesarean delivery with elective induction at 39 weeks. In the present desirability-of-outcome-ranking analysis, dyadic outcomes ranging from spontaneous vaginal delivery without severe neonatal complication (most desirable) to cesarean delivery with perinatal death (least desirable) were classified into 8 categories ranked by overall desirability by experienced investigators. Distributions of the desirability of outcome ranking were compared by estimating the probability of having a more desirable dyadic outcome with elective induction at 39 weeks of gestation than with expectant management. To account for various perspectives on these outcomes, a complementary analysis, called the partial credit strategy, was used to grade outcomes on a 100-point scale and estimate the difference in overall treatment scores between groups using a t test. RESULTS: All 6096 participants from the trial were included. The probability of a better dyadic outcome for a randomly selected patient who was randomized to elective induction was 53% (95% confidence interval, 51-54), implying that elective induction led to a better overall outcome for the dyad when taking multiple outcomes into account concurrently. Furthermore, the desirability-of-outcome-ranking probability of averting cesarean delivery with elective induction was 52% (95% confidence interval, 51-53), which was not at the expense of an operative vaginal delivery or a poorer outcome for the perinate (ie, survival with a severe neonatal complication or perinatal death). Randomization to elective induction was also advantageous in most of the partial credit score scenarios. CONCLUSION: Desirability-of-outcome-ranking methodology is a useful tool for obstetrical trials because it provides a concurrent view of the effect of an intervention on multiple dyadic outcomes, potentially allowing for better translation of data for decision-making and person-centered care.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sandoval GJ, Grobman WA, Evans SR, et al. Desirability of outcome ranking for obstetrical trials: illustration and application to the ARRIVE trial. Am J Obstet Gynecol. 2023. PMID: 37741532. doi:10.1016/j.ajog.2023.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。